{"transactions":[{"id":828039,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-25T19:08:28.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":56850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"12/48ths of the shares subject to the stock option will vest and become exercisable on March 23, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":56850,"derivative":{"exercise_price":40.73,"expiration_date":"2036-03-22","underlying":"Class A Common Stock","underlying_shares":56850},"source":{"system":"sec-edgar","filing":"0001614568-26-000008","document":"form4-03252026_110324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1614568/000161456826000008/form4-03252026_110324.xml","form_type":"4"}},{"id":828038,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-25T19:08:28.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":42403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") granted under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of May 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":42403,"source":{"system":"sec-edgar","filing":"0001614568-26-000008","document":"form4-03252026_110324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614568/000161456826000008/form4-03252026_110324.xml","form_type":"4"}},{"id":2597874,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-18T22:02:03.000Z","date":"2021-08-16","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":187468,"derivative":{"exercise_price":2.03,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-052311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121052311/doc4.xml","form_type":"4"}},{"id":2597873,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-08-18T22:02:03.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":2500,"price":26,"value":65000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-21-052311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121052311/doc4.xml","form_type":"4"}},{"id":2597872,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-08-18T22:02:03.000Z","date":"2021-08-16","kind":"exercise","acquired":true,"shares":2500,"price":2.03,"value":5075.0,"ownership":{"direct":true},"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-21-052311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121052311/doc4.xml","form_type":"4"}},{"id":2602305,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-16T20:31:24.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":189968,"derivative":{"exercise_price":2.03,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-051631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121051631/doc4.xml","form_type":"4"}},{"id":2602304,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-08-16T20:31:24.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":10000,"price":26,"value":260000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-21-051631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121051631/doc4.xml","form_type":"4"}},{"id":2602303,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-08-16T20:31:24.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":10000,"price":2.03,"value":20300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,563 shares acquired under the Employment Stock Purchase Plan on May 17, 2021."}],"balance_after":13125,"source":{"system":"sec-edgar","filing":"0001209191-21-051631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121051631/doc4.xml","form_type":"4"}},{"id":2755723,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-07T00:08:10.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":93340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":93340,"derivative":{"exercise_price":20.93,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":93340},"source":{"system":"sec-edgar","filing":"0001209191-21-025762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121025762/doc4.xml","form_type":"4"}},{"id":2782483,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-17T20:55:59.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":199968,"derivative":{"exercise_price":2.03,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-021392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121021392/doc4.xml","form_type":"4"}},{"id":2782482,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T20:55:59.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1487,"price":27.49,"value":40877.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $27.355 to $27.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1562,"source":{"system":"sec-edgar","filing":"0001209191-21-021392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121021392/doc4.xml","form_type":"4"}},{"id":2782481,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T20:55:59.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1013,"price":27.01,"value":27361.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $26.28 to $27.27. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3049,"source":{"system":"sec-edgar","filing":"0001209191-21-021392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121021392/doc4.xml","form_type":"4"}},{"id":2782480,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T20:55:59.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":2500,"price":2.03,"value":5075.0,"ownership":{"direct":true},"balance_after":4062,"source":{"system":"sec-edgar","filing":"0001209191-21-021392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121021392/doc4.xml","form_type":"4"}},{"id":2854665,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-17T21:55:29.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":202468,"derivative":{"exercise_price":2.03,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-011322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121011322/doc4.xml","form_type":"4"}},{"id":2854664,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T21:55:29.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":2500,"price":26.95,"value":67375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $26.52 to $27.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1562,"source":{"system":"sec-edgar","filing":"0001209191-21-011322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121011322/doc4.xml","form_type":"4"}},{"id":2854663,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T21:55:29.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":2500,"price":2.03,"value":5075.0,"ownership":{"direct":true},"balance_after":4062,"source":{"system":"sec-edgar","filing":"0001209191-21-011322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121011322/doc4.xml","form_type":"4"}},{"id":2904356,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-19T23:29:14.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":204968,"derivative":{"exercise_price":2.03,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-004102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121004102/doc4.xml","form_type":"4"}},{"id":2904355,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-01-19T23:29:14.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2500,"price":26,"value":65000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1562,"source":{"system":"sec-edgar","filing":"0001209191-21-004102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121004102/doc4.xml","form_type":"4"}},{"id":2904354,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Wright-Mitchell Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-01-19T23:29:14.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":2500,"price":2.03,"value":5075.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,562 shares acquired under the Employee Stock Purchase Plan on November 17, 2020."}],"balance_after":4062,"source":{"system":"sec-edgar","filing":"0001209191-21-004102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121004102/doc4.xml","form_type":"4"}},{"id":4459441,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":56003,"kind":"person","name":"Wright-Mitchell Jane","position":1,"cik":"0001614568","reported_name":"Mitchell Jane Wright","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2017-02-10T01:54:01.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":79500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Issued pursuant to the 2011 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% Acceleration upon Change of Control."}],"balance_after":79500,"derivative":{"exercise_price":3,"exercise_date":"2018-02-07","expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":79500},"source":{"system":"sec-edgar","filing":"0001437749-17-002063","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917002063/rdgdoc.xml","form_type":"4"}}]}